Inovio Pharmaceuticals
INO
#9062
Rank
NZ$0.19 B
Marketcap
NZ$2.85
Share price
-1.19%
Change (1 day)
-20.90%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.95. In 2024 the company made an earnings per share (EPS) of NZ-$6.79 an increase over its 2023 EPS that were of NZ-$10.47.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-29.28%
2024NZ-$6.79-35.14%
2023NZ-$10.47-56.62%
2022NZ-$24.15-19.54%
2021NZ-$30.0135.9%
2020NZ-$22.08-11.57%
2019NZ-$24.9715.24%
2018NZ-$21.67-2.78%
2017NZ-$22.296.93%
2016NZ-$20.84134.88%
2015NZ-$8.87-29.51%
2014NZ-$12.59-57.34%
2013NZ-$29.51146.55%
2012NZ-$11.9720.83%
2011NZ-$9.91-29.41%
2010NZ-$14.03-48.48%
2009NZ-$27.2410%
2008NZ-$24.7711.11%
2007NZ-$22.29-41.3%
2006NZ-$37.97-66.91%
2005NZ-$114.75110.61%
2004NZ-$54.48-61.63%
2003NZ-$141.99186.67%
2002NZ-$49.53
2001N/A-100%
2000NZ-$39.62-63.64%
1999NZ-$108.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.15-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.66-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.34-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.21-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.57-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.48-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ-$2.15-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA